van Kesteren, Ch <br/><br/>
Yondelis (trabectedin, ET-743): the development of an anticancer agent of marine origin.  [electronic resource] 

 -  Anti-cancer drugs  Aug 2003 
 - 487-502 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0959-4973 
<br/><br/><label>Standard No.: </label>10.1097/00001813-200308000-00001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Alkylating--adverse effects<br/>Cell Cycle--drug effects<br/>Chemistry, Pharmaceutical<br/>Clinical Trials as Topic<br/>Dioxoles--adverse effects<br/>Female<br/>Humans<br/>Isoquinolines--adverse effects<br/>Neoplasms--drug therapy<br/>Tetrahydroisoquinolines<br/>Trabectedin